The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Control of mammary stem cell function by steroid hormone signalling
Abstract
The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is therefore especially useful for finding similarities in gene expression patterns between different expression studies (57,59–61) (Figure 4C).”
From limma powers differential expression analyses for RNA-sequencing and microarray studies (2015) · cites this paper as [61]
Citations
Cites
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,082
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Self-citationIn vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,084
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005
Self-citationMice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.Preprint
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O’Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P. D., Ricketson, I., Shackleton, M. J., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,581
kConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–691 of 691
Nekritz, E. A., Barrueco, R. R., Yan, K., Davis, M. L., Werner, R. L., Devis, L., Mukhopadhyay, P., Yu, J., Llobet‐Navàs, D., & Silva, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442934 · Cited by 1
“After expansion, the mammary epithelium involutes to return to its original state; this process includes reduction of the number of MaSCs (Asselin-Labat et al., 2010).”
BackgroundNorthey, J. J., Yui, Y., Hayward, M.-K., Stashko, C., Kai, F., Mouw, J., Thakar, D., Lakins, J. N., Ironside, A., Samson, S., et al. (2022) · bioRxiv · doi:10.1101/2022.04.19.487741
Manipulating the hypoxic tumour microenvironment to study therapy resistance
Ient, J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210311jl · Cited by 1
Si, H., Mendoza, E. M., Esquivel, M., Creighton, C. J., Xu, J., & Roarty, K. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.25.640099 · Cited by 1
Progesterone Receptor Isoforms : functional Selectivity and Pharmacological Targeting
Khan, J. A. (2011) · theses.fr (ABES) · doi:10.70675/d565fcfezaed8z42f4za43az5b89ba52f3ae · Cited by 1
Breast Cancer Risk: Role of Somatic Breast Stem Cells
Eden, J. (2011) · Springer eBooks · doi:10.1007/978-94-007-2016-9_24
Park, S. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Cancer Treatment-Induced Bone Loss in Patients with Breast Cancer
Lipton, A., Dansey, R., & Coleman, R. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00060-1
Isolation and Characterization of Prostate Stem Cells
Goldstein, A. S., & Witte, O. N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6498-3_2
“For example, far greater numbers of mammary stem cell-enriched Lin - CD24 + CD29 hi cells can generate clonogenic colonies in vitro than can repopulate mammary gland structures in vivo (Asselin-Labat et al. 2010 ).”
BackgroundCatalano, F., Scandurra, G., Ravalli, C., Fraggetta, F., & Catanuto, G. (2014) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-5438-7_10
Novel Approaches to Breast Cancer Prevention and Inhibition of Metastases
Penninger, J. M. (2013)
Molecular Analysis of Breast Cancer Transcriptomes, Genomes, and Circulating Tumor DNA
Olsson, E. (2015) · Lund University Publications (Lund University)
The molecular landscape of the normal human breast – defining normal
Hilton, H. N., & Graham, J. D. (2014) · Breast Cancer Research · doi:10.1186/bcr3680
“Data derived from mouse models have shown that progesterone regulates the mammary stem cell compartment during pregnancy and the reproductive cycle [11,12], a mechanism suggested to account for the increased window of susceptibility to transformation at these times.”
BackgroundSau, A. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4050
“Several studies demonstrated that this was due to an indirect mechanism of action of estrogen and progesterone through paracrine signals (Asselin-Labat et al., 2006, 2010; Joshi et al., 2010; Lim et al., 2009).”
BackgroundMartin, T. J. (2011) · IBMS BoneKEy · doi:10.1138/20110540
Rakha, E. A. (2015) · Molecular pathology library · doi:10.1007/978-1-4939-2886-6_8
aaaaaaaaa. Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis
Brisken, C., Hess, K. P., & Jeitziner, R. (2015)
Current state of the evolving MMMN cancer progression models of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.022
The oncogenic properties of Amot80 in mammary epithelia
Ranahan, W. P. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1873
Genotoxic potential of nonsteroidal hormones
Topalović, D., Živković, L., Djelić, N., Bajić, V., Čabarkapa, A., Jović, S., & Spremo‐Potparević, B. (2015) · Veterinarski glasnik · doi:10.2298/vetgl1504245t
Zero to one: normal derived human ER+ cells in culture-proliferating
Hopkinson, B. M. (2016) · Receptors & Clinical Investigation · doi:10.14800/rci.1449
Investigation of the role of bovine mammary stem cells in the lactation cycle
Bowman, S. R. A. (2017) · The Sydney eScholarship Repository (The University of Sydney)
Sabaa, B. E., & Fayed, H. M. A. (2017) · Egyptian Journal of Pathology · doi:10.1097/01.xej.0000520762.56197.60
“the observed higher proliferative index among those patients (Asselin-Labat et al., 2010; Morrison et al., 2012; Azim and Partridge, 2014).”
BackgroundFolate and Folic Acid Supplement Use and Breast Cancer Risk in BRCA1/2 Mutation Carriers
Kim, S. J. (2016) · TSpace (University of Toronto)
Investigation of Ring Finger Protein 8 in Mammalian Physiology and Pathogenesis
Li, L. (2015) · TSpace (University of Toronto)
Jodlowski, T., & Ramesh, K. H. (2019) · Springer eBooks · doi:10.1007/978-981-13-5877-7_15
Molecular Dissection of Breast Luminal Transcription Networks
Bargiacchi, F. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/yxsj-a431
Barbieri, R. L. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00011-1
Mammary stem cells and their niche during aging
Broome, L. E., Bouamar, H., & Sun, L. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.05.003
Identifying Molecular Mechanisms of Progesterone-responsive Mammary Stem Cell Expansion
Shiah, Y.-J. (2014) · TSpace (University of Toronto)
Vyatkin, A. D., Otnyukov, D. V., Leonov, S. V., & Belikov, A. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.17.435828
Lineage-restricted Metabolic Identities of Mammary Epithelial Cells
Mahendralingam, M. J. (2019) · TSpace (University of Toronto)
Circulating RANKL, Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Zaman, T. (2018) · TSpace (University of Toronto)
Chemoprevention for Breast Cancer
Watanuki, R., Nagayama, A., Hayashida, T., & Kitagawa, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-4521-1_9
Rucci, N., Ventura, L., & Teti, A. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_7
Nakashima, T., & Takayanagi, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_633
Nakashima, T., & Takayanagi, H. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_633
Drapkin, R. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717955867.793460763
Nicolas, R., Rivas-Ruíz, R., Reyes‐López, A., & Ureña-Wong, K. (2022) · medRxiv · doi:10.1101/2022.09.29.22280276
Han, L., Wang, N., Li, Y., Jiang, S., & Gu, Y. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5201
“CCND1 and CDK6 are direct transcription targets of the transcriptional coactivator (TAZ), and the chemoprevention of BC may be achieved by suppressing MaSC function (48).”
Azim, H. A., Michiels, S., Bedard, P. L., Singhal, S. K., Criscitiello, C., Ignatiadis, M., Haibe‐Kains, B., Piccart, M. J., Sotiriou, C. P., & Loi, S. (2023) · doi:10.1158/1078-0432.22443108.v1
Data from SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function
Xue, Y., Lai, L., Lian, W., Tu, X., Zhou, J., Dong, P., Su, D., Wang, X., Cao, X., Chen, Y., et al. (2023) · doi:10.1158/1541-7786.c.6541048
Insights in the contributions of the RSPO-LGR pathway to breast cancer
ter Steege, E. J. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1929
Atypical Cell Cycle Regulation Promotes Mammary Stem Cell Expansion and Therapeutic ResistancePreprint
Fifield, B., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.05.583524
“An increase in proliferation coupled with alterations to the hormone receptor status in the mammary gland may impact the MaSC population, as this population is hormone receptor negative [50, 51].”
BackgroundZeng, P., Shu, L.-Z., Zhou, Y., Huang, H., Wei, S., Liu, W.-J., & Deng, H. (2024) · Stem Cells and Development · doi:10.1089/scd.2024.0035
“…to secrete amphiregulin (Areg) can activate the epidermal growth factor receptor (EGFR) on MaSCs, facilitating an increase in the ratio of SCD. 64 In the combination of gene sequencing of human mammary tissue and mouse models, it has been demonstrated that progesterone modulates the…”
Proceeding and Treatment of Breast Cancer in Pregnant Women
Mielniczek, K., Leśniewska, M., Chawrylak, K., Pelc, Z., Sędłąk, K., Polkowski, W. P., & Rawicz‐Pruszyński, K. (2025) · Archives of Medical Science · doi:10.5114/aoms/196998
“These cells are responsible for significant transformations that take place during the menstrual cycle, pregnancy, and lactation [13, 14].”
PR+ progenitors contribute to all mammary epithelial lineagesPreprint
Tharmapalan, P., Waas, M., McCloskey, C. W., Defamie, V., Aliar, K., Simões, B. M., Clarke, R. B., Howell, S. J., Kislinger, T., Berman, H. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.16.648786
“It is known that progesterone stimulates mammary stem and progenitor cell expansion 6,7,25 .”
A sex hormone-BDNF-TrkB axis directs sympathetic innervation in the mouse mammary glandPreprint
Maity, S., Krishnan, A., Cardoza, K. T., Frascoli, S. M., Joshi, D. M., Shah, A. B., Maiti, D., & Joshi, P. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.18.683256
Stromal Modulation of Radiation Carcinogenesis in Breast Cancer
Nguyen, D. H. H. (2011) · eScholarship (California Digital Library)
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740640
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26129656
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740646
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740643
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740655
Cornet, C. L., Jung, A. Y., Johnson, T., Behrens, S., Obi, N., Becher, H., Chang-Claude, J., & Fortner, R. T. (2023) · Figshare · doi:10.6084/m9.figshare.22649158
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102511
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740634
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740637
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102538
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740661
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102526
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102532
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740649
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102529
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740652
Ranjan, M., Lee, O., Cottone, G., Mehrabad, E. M., Spike, B. T., Zeng, Z., Yadav, S., Chatterton, R. T., Kim, J. J., Clare, S. E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15102535
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26129821
Carr, D., Zein, A. A., Coulombe, J., Jiang, T., Cabrita, M. A., Ward, G. C. D., Daneshmand, M., SAU, A. C., & Pratt, M. A. C. (2022) · Figshare · doi:10.6084/m9.figshare.20046002
Fifield, B.-A., Vusich, J., Haberfellner, E., Andrechek, E. R., & Porter, L. A. (2024) · Figshare · doi:10.6084/m9.figshare.26740658
Maternal Organ Growth: How the Adult Intestine Remodels During Pregnancy and Lactation
Ameku, T. (2025) · Development Growth & Differentiation · doi:10.1111/dgd.70037
“…with proliferation and differentiation of stem and progenitor cells reported in the brain (Chaker et al. 2023; Shingo et al. 2003), mammary gland (Asselin-Labat et al. 2010; Corral et al. 2025; Joshi et al. 2010), bone marrow (Nakada et al. 2014), kidney (Conte et al. 2025), and abdominal skin…”
Lee, E., & Kang, Y. (2026) · BioEssays · doi:10.1002/bies.70108
Widschwendter, M., Herzog, C. M. S., Rasul, M. F., Boggavarapu, N. R., Redl, E., Utjés, D., Rådestad, A. F., Danielsson, K. G., & Alkasalias, T. (2026) · Communications Medicine · doi:10.1038/s43856-026-01412-0
“For instance, in breast tissue, P promotes cell proliferation via the RANK pathway and acts as a pro-tumorigenic agent 7,8 Women carrying pathogenic BRCA1 variants exhibit higher P levels, which increases the risk of triple-negative breast cancer (TNBC) by enhancing the proliferation of PR-negative…”
A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic OnsetPreprint
Perrotta, R. M., Bertón, M., Salazar, L. E. V., Mahmoud, Y. D., Sáez, J. M. P., Dalotto‐Moreno, T., del Valle‐Pérez, B., Martínez‐Bosch, N., Morales, R. M., Gatto, S. G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.23.707584
Okamoto, K., & Takayanagi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00001-3
Chiche, A. (2012) · doi:10.70675/67609440zb6dez49d8z872az1256bad88650
“De plus, le microARN miR-9 est activé par Myc et inhibe l’expression de la E-cadhérine favorisant ainsi la formation de métastases (Ma et al., 2010).”
TOX3 – A candidate breast cancer predisposition gene
Schmidt, X. (2011) · theses.fr (ABES) · doi:10.70675/db4a6d31z3401z4ca4zbffaz3e0ea19675bd
“Several recent studies have shown that progesterone signalling induces proliferation of MaSC as well as tumour cells in a paracrine fashion that is mediated by the osteoclast differentiation factor RANKL (Asselin-Labat et al., 2010; Beleut et al., 2010; Fernandez-Gonzalez et al., 2010; Joshi et al., 2010; Schramek et…”
BackgroundRégulation des cellules initiatrices de tumeurs dans le cancer colorectal par la Progastrine
Giraud, J. (2013) · theses.fr (ABES) · doi:10.70675/4e0f05c4z6aaez40faz89a5z451a3e609f9b
Régulation de l’érythropoïèse : rôle des récepteurs à la transferrine et d’un phytoestrogène
Fouquet, G. (2019) · theses.fr (ABES) · doi:10.70675/ea62edc1z4e80z4d30z8220zdc73652aa716
Plasticité cellulaire et initiation tumorale dans le modèle du cancer du sein
Blander, H. D. (2020) · theses.fr (ABES) · doi:10.70675/c6b4eda8z19a5z4b3dzb7d9zacc5fd814b21
Hulsy, W. D., Salazar, K., Chalkia, D., Chavez, Y., Zhao, Y., Halkia, G., Razorenova, O. V., & Nikolaidis, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.16.732684
“Larger, deeply characterized, and cell-type-resolved studies will be required to determine whether these context-dependent differences have functional consequences for breast cancer susceptibility, tumor characteristics, progression, or population-associated disparities [1-9”
Yan, K., Nekritz, E. A., Xie, Z., Ju, B., Dong, X., Werner, R., Alsina‐Beauchamp, D., Rosencrance, C. D., Mukhopadhyay, P., Pan, Q., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117410
Hulsy, W. D., Salazar, K., Chalkia, D., Chavez, Y., Zhao, Y., Halkia, G., Razorenova, O. V., & Nikolaidis, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188279
Barash, I. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1982804
Translating Mammary Stem Cell and Cancer Stem Cell Biology to the Clinics
Pathania, R., Ganapathy, V., & Thangaraju, M. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_19
Metadata
- Authors
- Asselin-Labat, M.-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J., & Visvader, J. E.
- Affiliations
- Walter and Eliza Hall Institute of Medical Research (AU)
- The University of Melbourne (AU)
- Monash Medical Centre (AU)
- Oriental Yeast Co., Ltd. (Japan) (JP)
- St Vincents Institute of Medical Research (AU)
- The Royal Melbourne Hospital (AU)
- Corresponding author
- Lindeman, Geoffrey J.
- Visvader, Jane E.
- ORCID
- Venue
- Nature
- Published
- 2010-04-11
- Volume
- 465
- Issue
- 7299
- Pages
- 798-802
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2117963341
- Cited by
- 693
- References
- 38
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 29 · 2023: 22 · 2022: 29 · 2021: 30 · 2020: 30 · 2019: 32 · 2018: 40 · 2017: 44 · 2016: 45 · 2015: 63 · 2014: 53 · 2013: 64 · 2012: 76
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- mammary stem cells, steroid hormone signaling, estrogen, progesterone, RANKL, breast cancer risk, pregnancy, ovariectomy, letrozole, aromatase inhibition, chemoprevention, paracrine signaling, mammary gland development
- MeSH terms
- Letrozole, Animals, Aromatase, Cell Count, Estrogens, Female, Humans, Mammary Glands, Animal, Nitriles, Ovariectomy, Pregnancy, Pregnancy, Animal, Progesterone, Receptors, Estrogen, Receptors, Progesterone, Stem Cells, Triazoles, Signal Transduction, Integrin beta1, Paracrine Communication, Integrin beta3, Aromatase Inhibitors, Mice, CD24 Antigen, RANK Ligand, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review